At the time of writing, Edgewise Therapeutics Inc [EWTX] stock is trading at $15.75, up 1.94%. An important factor to consider is whether the stock is rising or falling in short-term value. The EWTX shares have gain 8.70% over the last week, with a monthly amount glided 6.28%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Edgewise Therapeutics Inc [NASDAQ: EWTX] stock has seen the most recent analyst activity on April 30, 2025, when Guggenheim initiated its Buy rating and assigned the stock a price target of $41. Previously, Scotiabank downgraded its rating to Sector Perform on April 02, 2025, and kept the price target unchanged to $14. On March 07, 2025, Scotiabank initiated with a Sector Outperform rating and assigned a price target of $50 on the stock. Stifel started tracking the stock assigning a Hold rating and suggested a price target of $30 on January 22, 2025. Evercore ISI initiated its recommendation with a Outperform and recommended $45 as its price target on November 22, 2024. Piper Sandler started tracking with a Overweight rating for this stock on March 07, 2024, and assigned it a price target of $48. In a note dated May 01, 2023, Truist initiated an Buy rating.
For the past year, the stock price of Edgewise Therapeutics Inc fluctuated between $10.60 and $38.12. Currently, Wall Street analysts expect the stock to reach $50 within the next 12 months. Edgewise Therapeutics Inc [NASDAQ: EWTX] shares were valued at $15.75 at the most recent close of the market. An investor can expect a potential return of 217.46% based on the average EWTX price forecast.
Analyzing the EWTX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is -0.31 and Total Capital is -0.39. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 15.27 points at the first support level, and at 14.78 for the second support level. However, for the 1st resistance point, the stock is sitting at 16.27, and for the 2nd resistance point, it is at 16.78.
Ratios To Look Out For
It is important to note that Edgewise Therapeutics Inc [NASDAQ:EWTX] has a current ratio of 20.99. On the other hand, the Quick Ratio is 20.99, and the Cash Ratio is 2.36.
Transactions by insiders
Recent insider trading involved Russell Alan J, Chief Scientific Officer, that happened on May 02 ’25 when 1551.0 shares were sold. General Counsel, MOORE JOHN R completed a deal on May 02 ’25 to sell 1930.0 shares. Meanwhile, President and CEO KOCH KEVIN sold 4276.0 shares on May 02 ’25.
